MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE
Tender information
TED EUValenciennes cedex, France
- Type
- 29
- Procedure
- oth-single
- Ref. number
- 814507-2025
- Estimated value
- 1,272,224 EUR
- CPV
- 33690000
MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE